3.59BMarket Cap
LossP/E TTM
Adaptive Biotechnologies Corp
ADPT Financials
See Adaptive Biotechnologies Corp's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Adaptive Biotechnologies Corp Earnings Date
Latest Release
Jul 29, 2026
EPS / Forecast
-0.25/-0.13
Revenue / Forecast
71.55M/65.89M
Revenue(YoY)
276.98M
54.77%
Analyst Rating
BUY
2026/08/01
FAQs
What is the total revenue of Adaptive Biotechnologies Corp?
According to Adaptive Biotechnologies Corp's FY2025 earnings report, its total revenue reached 276.98M, with a year-on-year change of 178.96M.
What are the current assets of Adaptive Biotechnologies Corp?
According to Adaptive Biotechnologies Corp's FY2025 earnings report, its current assets were 300.19M, with a year-on-year change of 5.79.
What are the total assets of Adaptive Biotechnologies Corp?
According to Adaptive Biotechnologies Corp's FY2025 earnings report, its total assets of Adaptive Biotechnologies Corp were 512.74M, with a year-on-year change of -4.94.
What are the total liabilities of Adaptive Biotechnologies Corp?
According to Adaptive Biotechnologies Corp's FY2025 earnings report, its total liabilities of Adaptive Biotechnologies Corp were 287.74M, with a year-on-year change of -14.59.
What is the total equity of Adaptive Biotechnologies Corp?
According to Adaptive Biotechnologies Corp's FY2025 earnings report, its total equity of Adaptive Biotechnologies Corp was 225.00M, with a year-on-year change of 11.12.
What is the net operating income of Adaptive Biotechnologies Corp?
According to Adaptive Biotechnologies Corp's FY2025 earnings report, its net operating income of Adaptive Biotechnologies Corp was -57.12M, with a year-on-year change of 62.75.
What is the net investment of Adaptive Biotechnologies Corp?
According to Adaptive Biotechnologies Corp's FY2025 earnings report, its net investment of Adaptive Biotechnologies Corp was 37.95M, with a year-on-year change of -51.22.
What is the net financing of Adaptive Biotechnologies Corp?
According to Adaptive Biotechnologies Corp's FY2025 earnings report, its net financing of Adaptive Biotechnologies Corp was 30.40M, with a year-on-year change of 12515.35.
What is the Earnings Per Share (EPS) of Adaptive Biotechnologies Corp?
According to Adaptive Biotechnologies Corp's FY2025 earnings report, its Earnings Per Share (EPS) was -0.39, with a year-on-year change of 63.83.
What is the net income of Adaptive Biotechnologies Corp?
According to Adaptive Biotechnologies Corp's FY2025 earnings report, its net income was -59.50M, with a year-on-year change of 62.69.
What is the net margin of Adaptive Biotechnologies Corp?
According to Adaptive Biotechnologies Corp's FY2025 earnings report, its net profit margin was -21.47, with a year-on-year change of 75.93.
What is the gross margin of Adaptive Biotechnologies Corp?
According to Adaptive Biotechnologies Corp's FY2025 earnings report, its gross margin was 73.62, with a year-on-year change of 25.27.
What is the debt-to-asset ratio of Adaptive Biotechnologies Corp?
According to Adaptive Biotechnologies Corp's FY2025 earnings report, its debt-to-asset ratio was 25.59, with a year-on-year change of 3.56.
What is the Return on Equity (ROE) of Adaptive Biotechnologies Corp?
According to Adaptive Biotechnologies Corp's FY2025 earnings report, its Return on Equity (ROE) was -28.23, with a year-on-year change of 54.76.
What is the Return on Assets (ROA) of Adaptive Biotechnologies Corp?
According to Adaptive Biotechnologies Corp's FY2025 earnings report, its Return on Assets (ROA) was -11.30, with a year-on-year change of 57.49.
What is the operating profit of Adaptive Biotechnologies Corp?
According to Adaptive Biotechnologies Corp's FY2025 earnings report, its operating profit was -57.12M, with a year-on-year change of 62.75.